APO RESEARCH · REPORT
Testosterone Replacement Therapy
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Product & engineering
Understand the product.
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Selected research
Industry Growth & Trends
Global Testosterone Replacement Therapy Industry Growth and Trends Forecast to 2032
Market perspective
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Testosterone Replacement Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Testosterone Replacement Therapy market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Testosterone Replacement Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Testosterone Replacement Therapy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Testosterone Replacement Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Testosterone Replacement Therapy Market by Company
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Testosterone Replacement Therapy Segment by Type
Gels
Injections
Patches
Other
Testosterone Replacement Therapy Segment by Application
Hospitals
Clinics
Others
Testosterone Replacement Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Testosterone Replacement Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Testosterone Replacement Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Testosterone Replacement Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Testosterone Replacement Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Testosterone Replacement Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gels
- Injections
- Patches
- Other
Applications
- Hospitals
- Clinics
- Others
Companies covered
- AbbVie
- Endo International
- Eli lilly
- Pfizer
- Actavis (Allergan)
- Bayer
- Novartis
- Teva
- Mylan
- Upsher-Smith
- Ferring Pharmaceuticals
- Kyowa Kirin
- Acerus Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Testosterone Replacement Therapy Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Testosterone Replacement Therapy Sales Estimates and Forecasts (2021-2032)
- 1.3 Testosterone Replacement Therapy Market by Type
- 1.3.1 Gels
- 1.3.2 Injections
- 1.3.3 Patches
- 1.3.4 Other
- 1.4 Global Testosterone Replacement Therapy Market Size by Type
- 1.4.1 Global Testosterone Replacement Therapy Market Size Overview by Type (2021-2032)
- 1.4.2 Global Testosterone Replacement Therapy Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Testosterone Replacement Therapy Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Testosterone Replacement Therapy Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Testosterone Replacement Therapy Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Testosterone Replacement Therapy Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Testosterone Replacement Therapy Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Testosterone Replacement Therapy Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Testosterone Replacement Therapy Industry Trends
- 2.2 Testosterone Replacement Therapy Industry Drivers
- 2.3 Testosterone Replacement Therapy Industry Opportunities and Challenges
- 2.4 Testosterone Replacement Therapy Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Testosterone Replacement Therapy Revenue (2021-2026)
- 3.2 Global Top Players by Testosterone Replacement Therapy Sales (2021-2026)
- 3.3 Global Top Players by Testosterone Replacement Therapy Price (2021-2026)
- 3.4 Global Testosterone Replacement Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Testosterone Replacement Therapy Major Company Production Sites & Headquarters
- 3.6 Global Testosterone Replacement Therapy Company, Product Type & Application
- 3.7 Global Testosterone Replacement Therapy Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Testosterone Replacement Therapy Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Testosterone Replacement Therapy Players Market Share by Revenue in 2025
- 3.8.3 2025 Testosterone Replacement Therapy Tier 1, Tier 2, and Tier 3
4 Testosterone Replacement Therapy Regional Status and Outlook
- 4.1 Global Testosterone Replacement Therapy Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Testosterone Replacement Therapy Historic Market Size by Region
- 4.2.1 Global Testosterone Replacement Therapy Sales in Volume by Region (2021-2026)
- 4.2.2 Global Testosterone Replacement Therapy Sales in Value by Region (2021-2026)
- 4.2.3 Global Testosterone Replacement Therapy Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Testosterone Replacement Therapy Forecasted Market Size by Region
- 4.3.1 Global Testosterone Replacement Therapy Sales in Volume by Region (2027-2032)
- 4.3.2 Global Testosterone Replacement Therapy Sales in Value by Region (2027-2032)
- 4.3.3 Global Testosterone Replacement Therapy Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Testosterone Replacement Therapy by Application
- 5.1 Testosterone Replacement Therapy Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Testosterone Replacement Therapy Market Size by Application
- 5.2.1 Global Testosterone Replacement Therapy Market Size Overview by Application (2021-2032)
- 5.2.2 Global Testosterone Replacement Therapy Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Testosterone Replacement Therapy Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Testosterone Replacement Therapy Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Testosterone Replacement Therapy Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Testosterone Replacement Therapy Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Testosterone Replacement Therapy Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Testosterone Replacement Therapy Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 AbbVie
- 6.1.1 AbbVie Company Information
- 6.1.2 AbbVie Business Overview
- 6.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 AbbVie Testosterone Replacement Therapy Product Portfolio
- 6.1.5 AbbVie Recent Developments
- 6.2 Endo International
- 6.2.1 Endo International Company Information
- 6.2.2 Endo International Business Overview
- 6.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Endo International Testosterone Replacement Therapy Product Portfolio
- 6.2.5 Endo International Recent Developments
- 6.3 Eli lilly
- 6.3.1 Eli lilly Company Information
- 6.3.2 Eli lilly Business Overview
- 6.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Eli lilly Testosterone Replacement Therapy Product Portfolio
- 6.3.5 Eli lilly Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Testosterone Replacement Therapy Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Actavis (Allergan)
- 6.5.1 Actavis (Allergan) Company Information
- 6.5.2 Actavis (Allergan) Business Overview
- 6.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Actavis (Allergan) Testosterone Replacement Therapy Product Portfolio
- 6.5.5 Actavis (Allergan) Recent Developments
- 6.6 Bayer
- 6.6.1 Bayer Company Information
- 6.6.2 Bayer Business Overview
- 6.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Bayer Testosterone Replacement Therapy Product Portfolio
- 6.6.5 Bayer Recent Developments
- 6.7 Novartis
- 6.7.1 Novartis Company Information
- 6.7.2 Novartis Business Overview
- 6.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Novartis Testosterone Replacement Therapy Product Portfolio
- 6.7.5 Novartis Recent Developments
- 6.8 Teva
- 6.8.1 Teva Company Information
- 6.8.2 Teva Business Overview
- 6.8.3 Teva Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Teva Testosterone Replacement Therapy Product Portfolio
- 6.8.5 Teva Recent Developments
- 6.9 Mylan
- 6.9.1 Mylan Company Information
- 6.9.2 Mylan Business Overview
- 6.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Mylan Testosterone Replacement Therapy Product Portfolio
- 6.9.5 Mylan Recent Developments
- 6.10 Upsher-Smith
- 6.10.1 Upsher-Smith Company Information
- 6.10.2 Upsher-Smith Business Overview
- 6.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Upsher-Smith Testosterone Replacement Therapy Product Portfolio
- 6.10.5 Upsher-Smith Recent Developments
- 6.11 Ferring Pharmaceuticals
- 6.11.1 Ferring Pharmaceuticals Company Information
- 6.11.2 Ferring Pharmaceuticals Business Overview
- 6.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Product Portfolio
- 6.11.5 Ferring Pharmaceuticals Recent Developments
- 6.12 Kyowa Kirin
- 6.12.1 Kyowa Kirin Company Information
- 6.12.2 Kyowa Kirin Business Overview
- 6.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Kyowa Kirin Testosterone Replacement Therapy Product Portfolio
- 6.12.5 Kyowa Kirin Recent Developments
- 6.13 Acerus Pharmaceuticals
- 6.13.1 Acerus Pharmaceuticals Company Information
- 6.13.2 Acerus Pharmaceuticals Business Overview
- 6.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Product Portfolio
- 6.13.5 Acerus Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Testosterone Replacement Therapy Sales by Country
- 7.1.1 North America Testosterone Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Testosterone Replacement Therapy Sales by Country (2021-2026)
- 7.1.3 North America Testosterone Replacement Therapy Sales Forecast by Country (2027-2032)
- 7.2 North America Testosterone Replacement Therapy Market Size by Country
- 7.2.1 North America Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Testosterone Replacement Therapy Market Size by Country (2021-2026)
- 7.2.3 North America Testosterone Replacement Therapy Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Testosterone Replacement Therapy Sales by Country
- 8.1.1 Europe Testosterone Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Testosterone Replacement Therapy Sales by Country (2021-2026)
- 8.1.3 Europe Testosterone Replacement Therapy Sales Forecast by Country (2027-2032)
- 8.2 Europe Testosterone Replacement Therapy Market Size by Country
- 8.2.1 Europe Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Testosterone Replacement Therapy Market Size by Country (2021-2026)
- 8.2.3 Europe Testosterone Replacement Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Testosterone Replacement Therapy Sales by Country
- 9.1.1 Asia-Pacific Testosterone Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Testosterone Replacement Therapy Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Testosterone Replacement Therapy Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Testosterone Replacement Therapy Market Size by Country
- 9.2.1 Asia-Pacific Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Testosterone Replacement Therapy Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Testosterone Replacement Therapy Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Testosterone Replacement Therapy Sales by Country
- 10.1.1 South America Testosterone Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Testosterone Replacement Therapy Sales by Country (2021-2026)
- 10.1.3 South America Testosterone Replacement Therapy Sales Forecast by Country (2027-2032)
- 10.2 South America Testosterone Replacement Therapy Market Size by Country
- 10.2.1 South America Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Testosterone Replacement Therapy Market Size by Country (2021-2026)
- 10.2.3 South America Testosterone Replacement Therapy Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Testosterone Replacement Therapy Sales by Country
- 11.1.1 Middle East and Africa Testosterone Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Testosterone Replacement Therapy Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Testosterone Replacement Therapy Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Testosterone Replacement Therapy Market Size by Country
- 11.2.1 Middle East and Africa Testosterone Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Testosterone Replacement Therapy Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Testosterone Replacement Therapy Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Testosterone Replacement Therapy Value Chain Analysis
- 12.1.1 Testosterone Replacement Therapy Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Testosterone Replacement Therapy Production Mode & Process
- 12.2 Testosterone Replacement Therapy Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Testosterone Replacement Therapy Distributors
- 12.2.3 Testosterone Replacement Therapy Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst